Familial Hypercholesterolemia: An Under‐recognized but Significant Concern in Cardiology Practice
- 5 November 2013
- journal article
- review article
- Published by Wiley in Clinical Cardiology
- Vol. 37 (2), 119-125
- https://doi.org/10.1002/clc.22223
Abstract
Familial hypercholesterolemia (FH) is a common disorder in which genetic mutations in at least 1 of several genes lead to significantly increased levels of lipoproteins, in particular, low‐density lipoprotein cholesterol. Most commonly, mutations in the low‐density lipoprotein receptor gene result in high plasma levels of apolipoprotein B‐containing lipoproteins (eg, low‐density lipoprotein and lipoprotein(a)). High plasma levels of lipoproteins increase the risk of cardiovascular events by as much as 20‐fold if left untreated. A 2011 survey of cardiologists performed by the American College of Cardiology (ACC) suggests that there is a need for greater awareness of FH among cardiologists with regard to its prevalence and heritability, and of the risk of cardiovascular (CV) disease associated with the disorder, such as premature coronary heart disease. Given that many patients with FH may first present to CV specialists at the time of a major coronary event, it is critical that cardiologists have strategies to manage this high‐risk subset of patients. This brief review responds to areas of need identified in the ACC survey and is intended to provide current information about FH and increase awareness about this disorder among cardiologists.Keywords
This publication has 27 references indexed in Scilit:
- Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering TherapyCirculation, 2011
- Management of Familial Hypercholesterolemias in adult patients: Recommendations from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology, 2011
- Future issues, public policy, and public awareness of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology, 2011
- Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology, 2011
- Treatment of adults with Familial Hypercholesterolemia and evidence for treatment: Recommendations from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology, 2011
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patientsJournal of Clinical Lipidology, 2011
- Sudden Death in a 4-Year-Old Boy: A Near-Complete Occlusion of the Coronary Artery Caused by an Aggressive Low-Density Lipoprotein Receptor Mutation (W556R) in Homozygous Familial HypercholesterolemiaThe Journal of Pediatrics, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemiaAtherosclerosis, 2003
- Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular geneticsThe American Journal of Cardiology, 1993